ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 992 shares, the number of shares held decreased 3.8% compared to the previous period and now represents 1.01% of the total position.
ARKG Investment Tracker position change: Cleared position in Regeneron Pharmaceuticals by 12,246 shares, the number of shares held decreased 100% compared to the previous period and now represents 0% of the total position.
ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 190,592 shares, the number of shares held decreased 3.8% compared to the previous period and now represents 1.49% of the total position.
ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 3,968 shares, the number of shares held decreased 3.8% compared to the previous period and now represents 1.22% of the total position.
ARKG Investment Tracker position change: Decreased position in Veeva by 1,536 shares, the number of shares held decreased 3.73% compared to the previous period and now represents 1.07% of the total position.
ARKG Investment Tracker position change: Decreased position in Atai Beckley Inc by 126,144 shares, the number of shares held decreased 3.8% compared to the previous period and now represents 1.22% of the total position.
ARKG Investment Tracker position change: Decreased position in Amgen by 3,506 shares, the number of shares held decreased 7.3% compared to the previous period and now represents 1.39% of the total position.
ARKG Investment Tracker position change: Decreased position in Incyte by 5,184 shares, the number of shares held decreased 3.79% compared to the previous period and now represents 1.29% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 72,832 shares, the number of shares held decreased 3.8% compared to the previous period and now represents 2.94% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 122,944 shares, the number of shares held decreased 3.8% compared to the previous period and now represents 2.5% of the total position.